| Literature DB >> 28178759 |
Hiroyo Ninomiya1, Naoto Katakami1,2, Taka-Aki Matsuoka1, Mitsuyoshi Takahara1,3, Hitoshi Nishizawa1, Norikazu Maeda1, Michio Otsuki1, Akihisa Imagawa1, Hiroyasu Iso4, Tetsuya Ohira5, Iichiro Shimomura1.
Abstract
AIMS/Entities:
Keywords: Diabetic nephropathy; Psychosocial factors; Social support
Mesh:
Year: 2017 PMID: 28178759 PMCID: PMC5754535 DOI: 10.1111/jdi.12641
Source DB: PubMed Journal: J Diabetes Investig ISSN: 2040-1116 Impact factor: 4.232
Baseline characteristics of participants with or without diabetic nephropathy
| Total | Non‐diabetic nephropathy | Diabetic nephropathy |
| |
|---|---|---|---|---|
| Sex (male) | 194 (56.6%) | 115 (52.3%) | 79 (64.2%) | 0.032 |
| Age | 65.1 ± 9.5 | 64.9 ± 9.0 | 65.4 ± 10.4 | 0.654 |
| Duration of diabetes (years) | 15.1 ± 9.9 | 13.9 ± 9.5 | 17.2 ± 10.3 | 0.003 |
| Body mass Index (kg/m2) | 25.9 ± 5.3 | 25.6 ± 5.3 | 26.5 ± 5.3 | 0.154 |
| Systolic blood pressure (mmHg) | 131.6 ± 16.4 | 130.1 ± 15.4 | 134.4 ± 17.9 | 0.020 |
| Diastolic blood pressure (mmHg) | 75.0 ± 12.2 | 74.9 ± 11.3 | 75.1 ± 13.8 | 0.845 |
| Alcohol (once a week or more) | 115 (33.9%) | 76 (34.7%) | 39 (32.5%) | 0.682 |
| Current smoker | 43 (12.6%) | 19 (8.7%) | 24 (19.7%) | 0.003 |
| HbA1c (%) | 7.8 ± 1.5 | 7.8 ± 1.4 | 7.9 ± 1.7 | 0.632 |
| Glycated albumin (%) | 21.0 ± 5.1 | 21.3 ± 5.1 | 20.6 ± 5.1 | 0.243 |
| Creatinine (mg/dL) | 0.99 ± 1.1 | 0.78 ± 0.20 | 1.35 ± 1.71 | <0.001 |
| eGFR (mL/min/1.73 m2) | 66.7 ± 20.6 | 70.5 ± 16.1 | 59.9 ± 25.4 | <0.001 |
| Total‐cholesterol (mg/dL) | 188.5 ± 37.3 | 187.3 ± 37.4 | 190.8 ± 37.2 | 0.429 |
| Triglyceride (mg/dL) | 117 (84–169) | 105 (76–155) | 139 (104–185) | <0.001 |
| LDL cholesterol (mg/dL) | 106.7 ± 28.0 | 106.9 ± 26.7 | 106.3 ± 30.2 | 0.834 |
| HDL cholesterol (mg/dL) | 54.4 ± 16.5 | 55.9 ± 16.2 | 51.9 ± 16.9 | 0.036 |
| Hypertension | 240 (70.0%) | 141 (64.1%) | 99 (80.5%) | 0.001 |
| Dyslipidemia | 226 (65.9%) | 135 (61.4%) | 91 (74.0%) | 0.018 |
| Malignancy | 75 (21.9%) | 55 (25.0%) | 20 (16.3%) | 0.060 |
| Macroangiopathy | 68 (19.8%) | 27 (12.3%) | 41 (33.3%) | <0.001 |
| Nephropathy | – | – | ||
| Microalbuminuria | 75 (61.0%) | |||
| Macroalbuminuria and eGFR ≥30 (mL/min/1.73 m2) | 33 (26.8%) | |||
| Macroalbuminuria and eGFR <30 (mL/min/1.73 m2) | 11 (8.9%) | |||
| Under dialysis | 4 (3.3%) | |||
| Retinopathy ( | 104 (33.3%) | 43 (21.3%) | 61 (55.5%) | <0.001 |
| Neuropathy ( | 153 (46.6%) | 91 (42.7%) | 62 (53.9%) | 0.053 |
| Medications | ||||
| Antidiabetics | 314 (91.5%) | 197 (89.5%) | 117 (95.1%) | 0.075 |
| Insulin | 115 (33.5%) | 59 (26.8%) | 56 (45.5%) | <0.001 |
| Antihypertensives | 223 (65.0%) | 130 (59.1%) | 93 (75.6%) | 0.002 |
| Renin–angiotensin system inhibitor | 182 (53.1%) | 104 (47.3%) | 78 (63.4%) | 0.004 |
| Lipid‐lowering drug | 174 (50.7%) | 107 (48.6%) | 67 (54.5%) | 0.300 |
| Psychosocial factors | ||||
| Happiness score (range 1–10, higher = happier) | 7.3 ± 1.7 | 7.5 ± 1.6 | 6.9 ± 1.9 | 0.003 |
| Optimism: LOT‐R ( | 13.5 ± 3.1 | 13.7 ± 3.1 | 13.0 ± 3.0 | 0.033 |
| Laughter frequency ( | ||||
| Non‐every day laughers | 205 (60.3%) | 129 (58.6%) | 76 (63.3%) | 0.398 |
| Almost every day laughers | 135 (39.7%) | 91 (41.4%) | 44 (36.7%) | |
| Self‐awareness of stress ( | ||||
| More stress (‘always’ and ‘often’) | 113 (33.0%) | 63 (28.8%) | 50 (40.7%) | 0.025 |
| Less stress (‘sometimes’ and ‘rarely’) | 229 (67.0%) | 156 (71.2%) | 73 (59.3%) | |
| Social network: SNI ( | ||||
| Low connection (SNI score; 0 and 1) | 153 (45.4%) | 87 (40.3%) | 66 (54.5%) | 0.012 |
| High connection (SNI score; 2–4) | 184 (54.6%) | 129 (59.7%) | 55 (45.5%) | |
| Social support: ESSI ( | ||||
| Less support (ESSI score: 5–26) | 176 (52.4%) | 102 (47.2%) | 74 (61.7%) | 0.011 |
| More support (ESSI score: 27–31) | 160 (47.6%) | 114 (52.8%) | 46 (38.3%) | |
Values are shown as mean ± standard deviation, median (interquartile) or number (percentage). Quantitative data between the groups of non‐diabetic and diabetic nephropathy were compared by two‐tailed unpaired t‐test or Mann–Whitney test, depending on the distribution pattern of the data. Categorical data were analyzed using the χ2‐test or Fisher's exact test. The threshold of statistical significance was defined as P < 0.05. Macrovascular disease includes ischemic heart disease, cerebrovascular disease and peripheral artery disease. Microalbuminuria is urinary albumin and creatinine ≥30 and <300 mg/gCr, and macroalbuminuria is urinary albumin and creatinine ≥300 mg/gCr. eGFR, estimated glomerular filtration rate; ESSI, the Enhancing Recovery in Coronary Heart Disease Patients Social Support Instrument; HbA1c, hemoglobin A1c; HDL‐C, high density lipoprotein cholesterol; LDL‐C, low density lipoprotein cholesterol; LOT‐R, Life Orientation Test‐revised; SNI, the Social Network Index; UACR, urinary albumin‐to‐creatinine ratio.
Figure 1The relationships among indicators of psychosocial factors. Relationships among six indicators of psychosocial factors were assessed using Spearman's rank correlation coefficient. The strength of the relationship is shown by ρ‐values and the width of the connecting line.
Associations between psychosocial factors and clinical characteristics (health behaviors and complicated disease)
| Current smoker | Alcohol consumption frequency | Hypertension | Dyslipidemia | Medication for diabetes | Use of insulin | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OR (95% CI) |
| OR (95% CI) |
| OR (95% CI) |
| OR (95% CI) |
| OR (95% CI) |
| OR (95% CI) |
| |
| Happiness score (range 1–10, higher = happier) | 0.97 (0.70–1.36) | 0.893 | 1.25 (0.98–1.61) | 0.076 | 0.83 (0.65–1.05) | 0.123 | 0.91 (0.72–1.15) | 0.422 | 1.06 (0.73–1.53) | 0.772 | 0.97 (0.77–1.21) | 0.783 |
| Optimism (LOT‐R) (range 0–24, higher = greater optimism) | 1.09 (0.78–1.53) | 0.620 | 1.58 (1.22–2.07) | 0.001 | 0.84 (0.66–1.07) | 0.159 | 0.90 (0.71–1.14) | 0.366 | 1.14 (0.78–1.67) | 0.505 | 1.03 (0.82–1.31) | 0.776 |
| Laughter frequency (non‐every day/almost every day) | 1.41 (0.71–2.82) | 0.327 | 1.81 (1.09–3.03) | 0.023 | 0.84 (0.51–1.37) | 0.482 | 1.02 (0.64–1.64) | 0.939 | 1.96 (0.83–4.66) | 0.127 | 1.28 (0.80–2.04) | 0.307 |
| Self‐awareness of stress (more‐stress/less‐stress) | 1.31 (0.63–2.75) | 0.465 | 1.80 (1.05–3.11) | 0.033 | 1.14 (0.69–1.89) | 0.608 | 0.71 (0.43–1.17) | 0.181 | 0.63 (0.26–1.53) | 0.312 | 1.11 (0.68–1.81) | 0.688 |
| Social network (low‐connection/high‐connection) | 1.33 (0.68–2.62) | 0.402 | 1.47 (0.90–2.40) | 0.125 | 0.58 (0.36–0.95) | 0.031 | 1.55 (0.98–2.44) | 0.062 | 1.11 (0.52–2.38) | 0.792 | 0.73 (0.46–1.15) | 0.172 |
| Social support (less‐support/more‐support) | 1.34 (0.67–2.68) | 0.408 | 1.04 (0.63–1.70) | 0.884 | 0.70 (0.43–1.14) | 0.152 | 1.57 (0.98–2.52) | 0.060 | 2.04 (0.90–4.62) | 0.088 | 0.94 (0.59–1.49) | 0.780 |
Logistic regression analyses adjusted for sex and age were carried out to select the psychosocial factors significantly associated with clinical characteristics (current smoking, alcohol consumption, presence of hypertension, presence of dyslipidemia, medication for diabetes and use of Insulin.). Odds ratios (OR) (95% confidence interval [CI]) per 1 standard deviation are shown for the happiness score and Life Orientation Test‐revised (LOT‐R) score. The threshold of statistical significance was defined as P < 0.05. Alcohol consumption frequency was defined as drinking alcohol more than once per week.
Relationships between psychosocial factors and clinical parameters
| Duration of diabetes (years) | BMI (kg/m2) | HbA1c (%) | GA (%) | SBP (mmHg) | T‐chol (mg/dL) | TG (mg/dL) | LDL‐C (mg/dL) | HDL‐C (mg/dL) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| β |
| β |
| β |
| β |
| β |
| β |
| β |
| β |
| β |
| |
| Happiness score (range 1–10, higher = happier) | −0.02 | 0.687 | −0.13 | 0.012 | −0.08 | 0.159 | −0.09 | 0.122 | 0.04 | 0.424 | −0.10 | 0.073 | −0.08 | 0.117 | −0.12 | 0.026 | −0.05 | 0.377 |
| Optimism (LOT‐R) (range 0–24, higher =greater optimism) | 0.04 | 0.429 | −0.02 | 0.644 | −0.01 | 0.883 | −0.01 | 0.834 | −0.00 | 0.953 | 0.02 | 0.751 | −0.01 | 0.896 | −0.01 | 0.791 | 0.02 | 0.710 |
| Laughter frequency (non‐every day/almost every day) | −0.05 | 0.375 | 0.06 | 0.225 | 0.01 | 0.899 | 0.01 | 0.935 | −0.00 | 0.950 | −0.08 | 0.157 | 0.02 | 0.743 | −0.12 | 0.025 | −0.04 | 0.439 |
| Self‐awareness of stress (more stress/less stress) | −0.00 | 0.999 | 0.01 | 0.871 | 0.01 | 0.878 | −0.05 | 0.431 | −0.06 | 0.254 | −0.12 | 0.035 | −0.02 | 0.682 | −0.13 | 0.017 | 0.02 | 0.784 |
| Social network (low connection/high connection) | 0.00 | 0.979 | −0.06 | 0.269 | 0.04 | 0.445 | 0.03 | 0.565 | −0.03 | 0.571 | −0.04 | 0.509 | −0.06 | 0.297 | 0.01 | 0.839 | −0.07 | 0.221 |
| Social support (less support/more support) | −0.04 | 0.414 | 0.01 | 0.846 | 0.00 | 0.981 | −0.09 | 0.121 | −0.02 | 0.707 | −0.09 | 0.137 | 0.09 | 0.116 | −0.11 | 0.051 | −0.06 | 0.290 |
Multivariate linear regression analyses adjusted for sex and age were carried out to select the psychosocial factors significantly associated with clinical characteristics. The threshold of statistical significance was defined as P < 0.05. BMI, body mass index; HbA1c, hemoglobin A1c; HDL‐C, high density lipoprotein cholesterol; GA, glycoalbumin; LDL‐C, low density lipoprotein cholesterol; LOT‐R, Life Orientation Test‐revised; SBP, systolic blood pressure; T‐chol, total cholesterol; TG, triglyceride.
Figure 2Odds ratios (OR) for diabetic nephropathy of six indicators of psychosocial factors adjusted for age and sex. Logistic regression analysis was carried out to evaluate whether psychosocial factors were significantly associated with an increase in the risk of diabetic nephropathy. The threshold of statistical significance was defined as P < 0.05. The OR of ‘happiness score’ and ‘optimism’ are shown as per 1 standard deviation. In the logistic regression analysis adjusted for age and sex, a high happiness score (OR per 1 standard deviation 0.72, 95% CI: 0.57–0.90, P = 0.004), high LOT‐R score (OR per 1 standard deviation 0.79, 95% CI: 0.62–0.99, P = 0.044), less self‐awareness of stress (OR 0.59, 95% CI: 0.36–0.94, P = 0.028), high connection of social network (OR 0.57, 95% CI: 0.37–0.90, P = 0.015) and more social support (OR 0.61, 95% CI: 0.38–0.96, P = 0.042) were associated with reduced risk of presence of diabetic nephropathy. CI, confidence interval; LOT‐R, Life Orientation Test‐revised; OR, odds ratio.
Multivariate associations with diabetic nephropathy and psychosocial factors
| Model 1 | Model 2 | Model 3 | Model 4 | |||||
|---|---|---|---|---|---|---|---|---|
| OR (95% CI) |
| OR (95% CI) |
| OR (95% CI) |
| OR (95% CI) |
| |
| Happiness score (range 1–10, higher = happier) | 0.74 (0.58–0.93) | 0.011 | 0.74 (0.58–0.94) | 0.013 | 0.74 (0.58–0.94) | 0.013 | 0.72 (0.56–0.92) | 0.008 |
| Optimism: LOT‐R (range 0–24, higher = greater optimism) | 0.74 (0.57–0.97) | 0.026 | 0.74 (0.57–0.97) | 0.027 | 0.74 (0.57–0.97) | 0.027 | 0.71 (0.54–0.93) | 0.013 |
| Laughter frequency (non‐every day/almost every day) | 0.90 (0.55–1.48) | 0.678 | 0.92 (0.56–1.52) | 0.747 | 0.91 (0.55–1.51) | 0.725 | 0.79 (0.47–1.34) | 0.388 |
| Self‐awareness of stress (more stress/less stress) | 0.51 (0.31–0.85) | 0.010 | 0.54 (0.32–0.90) | 0.019 | 0.54 (0.32–0.91) | 0.021 | 0.49 (0.29–0.83) | 0.008 |
| Social network (low connection/high connection) | 0.53 (0.33–0.86) | 0.010 | 0.55 (0.34–0.89) | 0.015 | 0.55 (0.34–0.90) | 0.016 | 0.54 (0.33–0.90) | 0.017 |
| Social support (less support/more support) | 0.57 (0.35–0.93) | 0.026 | 0.59 (0.36–0.98) | 0.040 | 0.59 (0.36–0.97) | 0.038 | 0.51 (0.30–0.86) | 0.011 |
Multivariate logistic regression analysis was carried out to evaluate whether positive psychosocial factors were significantly associated with an increase in the risk of diabetic nephropathy. The threshold of statistical significance was defined as P < 0.05. Odds ratios (OR) (95% confidence interval [CI]) per 1 standard deviation are shown for the happiness score and Life Orientation Test‐revised (LOT‐R) score. Model 1: adjusted for age, sex, duration of diabetes mellitus, hypertension, dyslipidemia, current smoker and hemoglobin A1c. Model 2: adjusted for all factors in Model 1, plus body mass index and systolic blood pressure. Model 3: adjusted for all factors in model 1, plus body mass index, systolic blood pressure and treatment with an renin‐angiotensin system (RAS) inhibitor. Model 4: adjusted for all factors in model 1, plus body mass index, systolic blood pressure, treatment with an RAS and the presence of macroangiopathy.